Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients

Background. Belatacept-based therapy in kidney transplant recipient has been shown to increase long-term renal allograft and patient survival compared with calcineurin inhibitor–based therapy, however, with an increased risk of acute T cell-mediated rejection (aTCMR). An improved understanding of co...

Full description

Bibliographic Details
Main Authors: Marieke van der Zwan, MD, Carla C. Baan, PhD, Robert B. Colvin, MD, PhD, Rex N. Smith, MD, PhD, Rebecca A. White, Dorothy Ndishabandi, Alex L. Nigg, Thierry P.P. van den Bosch, PhD, Gretchen N. de Graav, MD, PhD, Marian C. Clahsen-van Groningen, MD, PhD, Dennis A. Hesselink, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2019-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000857

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000857

Similar Items